About NeuSpera Medical
NeuSpera Medical is a company based in Santa Clara (United States) founded in 2014 by Alexander Yeh.. NeuSpera Medical has raised $123.59 million across 4 funding rounds from investors including Olympus, Windham Capital Partners and Vertex Ventures HC. NeuSpera Medical offers products and services including Neuspera Implantable SNM System. NeuSpera Medical operates in a competitive market with competitors including Axonics, Amber Therapeutics, UroMems, MyoPowers Medical Technologies and Levee Medical, among others.
- Headquarter Santa Clara, United States
- Founders Alexander Yeh
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neuspera Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$123.59 M (USD)
in 4 rounds
-
Latest Funding Round
$23 M (USD), Series D
Jul 15, 2024
-
Investors
Olympus
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuSpera Medical
NeuSpera Medical offers a comprehensive portfolio of products and services, including Neuspera Implantable SNM System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Implantable system for treating urinary urgency via nerve stimulation.
Unlock access to complete
Unlock access to complete
Funding Insights of NeuSpera Medical
NeuSpera Medical has successfully raised a total of $123.59M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $23 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $23.0M
-
First Round
First Round
(13 Jun 2016)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series D - NeuSpera Medical | Valuation | Vertex Ventures HC , Treo Ventures | |
| Jun, 2021 | Amount | Series C - NeuSpera Medical | Valuation |
investors |
|
| Jan, 2018 | Amount | Series B - NeuSpera Medical | Valuation | 6 Dimensions Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuSpera Medical
NeuSpera Medical has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Olympus, Windham Capital Partners and Vertex Ventures HC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investments are focused on breakthrough healthcare solutions.
|
Founded Year | Domain | Location | |
|
Life-Sciences focused early and growth stage VC firm funding companies in China & the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuSpera Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuSpera Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neuspera Medical Comparisons
Competitors of NeuSpera Medical
NeuSpera Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Amber Therapeutics, UroMems, MyoPowers Medical Technologies and Levee Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| domain | founded_year | HQ Location |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of active implantable devices for urological incontinence
|
|
| domain | founded_year | HQ Location |
An implantable device for the treatment of urinary incontinence stress
|
|
| domain | founded_year | HQ Location |
Urological devices for post-prostatectomy incontinence are developed by Levee Medical.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neuspera Medical
Frequently Asked Questions about NeuSpera Medical
When was NeuSpera Medical founded?
NeuSpera Medical was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is NeuSpera Medical located?
NeuSpera Medical is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Is NeuSpera Medical a funded company?
NeuSpera Medical is a funded company, having raised a total of $123.59M across 4 funding rounds to date. The company's 1st funding round was a Series B of $26M, raised on Jun 13, 2016.
What does NeuSpera Medical do?
NeuSpera Medical was founded in 2014 and is headquartered in Santa Clara, United States. Implantable neuromodulation technologies are developed by the company to address chronic conditions such as epilepsy and heart failure. As of 2015, regulatory approvals were obtained for three implantable devices and one wearable device used for remote patient monitoring. Advancements include closed-loop vagus nerve stimulation therapy, with operations focused on the medical device sector.
Who are the top competitors of NeuSpera Medical?
NeuSpera Medical's top competitors include Axonics, Amber Therapeutics and UroMems.
What products or services does NeuSpera Medical offer?
NeuSpera Medical offers Neuspera Implantable SNM System.
Who are NeuSpera Medical's investors?
NeuSpera Medical has 8 investors. Key investors include Olympus, Windham Capital Partners, Vertex Ventures HC, Treo Ventures, and 6 Dimensions Capital.